Seraxis Announced Closing of $40M Series C Financing Round
- Tuesday, February 9, 2021, 7:15
- Environment
- Add a comment
GERMANTOWN, Md., Feb. 9, 2021 /PRNewswire/ — Seraxis, a biotech company developing a cell replacement therapy for insulin-dependent diabetes today announced the successful closing of a $40M Series C private financing round. The financing was led by Eli Lilly and Company, with…
About the Author
adminasapcorp has written 39609 stories on this site.